Literature DB >> 17080330

Pathology and molecular biology of teratomas in childhood and adolescence.

D Harms1, S Zahn, U Göbel, D T Schneider.   

Abstract

The biologic behaviour of teratomas depends on various interdependent clinical and epidemiologic variables such as the age at diagnosis, sex, tumor site, histology which all correlate to different cytogenetic and molecular biologic aberrations. Thus, testicular teratomas of infancy are generally benign. Accordingly, prepubertal teratomas show no cytogenetic or molecular genetic aberrations. In contrast, postpubertal testicular teratomas can present as clinically malignant tumors and may show complex cytogenetic aberrations such as the isochromosome 12p, which is pathognomonic of malignant germ cell tumors. Notably, teratomas of both age groups show an at least partial erasure of the genomic imprinting, correlating with their origin from primordial germ cells. The Kiel Pediatric Tumor Registry includes 541 teratoma specimens, and among these, the most frequent tumor sites (in descending order) are: the sacrococcygeal region (33.8 %), the ovaries (31.2 %) and the testes (10.5 %). Rare localizations include the mediastinum, the retroperitoneum, the head and neck region as well as the central nervous system. The WHO classification of germ cell tumors distinguishes mature and immature teratomas as well as teratomas with malignant transformation. In immature teratomas, primitive neuroectodermal structures predominate. According to the grading system (Gonzalez-Crussi, 1982), mature teratomas (G0) are more frequent (54.5 %) than immature teratomas (G1-G3, 45.5 %). Only 7.8 % of all teratomas show the highest grade of immaturity (G3). The frequency of additional microscopic foci of malignant yolk sac tumor correlates with the grade of immaturity. In sacrococcygeal teratomas, the yolk sac tumor microfoci may give rise to a malignant relapse after incomplete resection. The rare teratomas with malignant transformation contain components with "conventional" somatic type malignancy such as leukaemia, carcinoma or sarcoma. Here, molecular genetic analysis has demonstrated the origin of the somatic malignancy from a malignant transformation within the germ cell tumor with retention of the cytogenetic changes characteristic of malignant germ cell tumors.

Entities:  

Mesh:

Year:  2006        PMID: 17080330     DOI: 10.1055/s-2006-942271

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  33 in total

Review 1.  Neonatal tumours.

Authors:  Kokila Lakhoo; Helen Sowerbutts
Journal:  Pediatr Surg Int       Date:  2010-10-19       Impact factor: 1.827

2.  Miserable 9 Years of Life: a Misdiagnosed and Mismanaged Case of Large Retroperitoneal Teratoma.

Authors:  Shivpal Saini; Mufaddal Kazi; Sajid S Qureshi
Journal:  Indian J Surg Oncol       Date:  2020-07-27

3.  Case Report: a Case of Jejunal Mesenteric Teratoma in Adult Male: a Rare Case.

Authors:  Nischal Raj; Vidyadish S Bagalkot
Journal:  Indian J Surg Oncol       Date:  2020-06-22

4.  Hamartomatous Polyp of the Nasopharynx: A Rare Case Report.

Authors:  Amitav Shukla; Trishna Kakad; Saloni Shah; Anita S Bhaduri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-06

5.  Enlarging teratoma syndrome.

Authors:  İdris Sertbaş; Mete Karatay
Journal:  Childs Nerv Syst       Date:  2018-08-29       Impact factor: 1.475

6.  Carcinoid tumor arising in a mature cystic teratoma: A case report.

Authors:  Zeynep Tosuner; Fatma Cavide Sönmez; Dilek Sema Arici; Ramazan Dansuk
Journal:  Oncol Lett       Date:  2015-02-27       Impact factor: 2.967

7.  Glial fibrillary acidic protein expression is an indicator of teratoma maturation in children.

Authors:  Song Gu; Ye-Ming Wu; Li Hong; Zhong-De Zhang; Min-Zhi Yin
Journal:  World J Pediatr       Date:  2011-01-05       Impact factor: 2.764

8.  Immature teratoma and subsequent acute promyelocytic leukemia in a pediatric patient with XYY syndrome.

Authors:  Ju Heon Park; Hyun Woo Choi; Bo Young Seo; Min Goo Kang; Soo Hyun Kim; Hee Jo Baek; Hoon Kook; Myung Geun Shin
Journal:  Ann Lab Med       Date:  2015-09       Impact factor: 3.464

9.  [Teratoma of the ovary. Clinical and pathological differences between mature and immature teratomas].

Authors:  D Schmidt; F Kommoss
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

Review 10.  Management of fetal teratomas.

Authors:  Jose L Peiró; Lourenço Sbragia; Federico Scorletti; Foong Y Lim; Aimen Shaaban
Journal:  Pediatr Surg Int       Date:  2016-04-25       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.